Resources

In part 3 of this Exclusive Interview, Judith Wylie-Rosett shares the results of trials studying the effects of using sweeteners in a conversation with Diabetes in Control Publisher Steve Freed.

In part 4 of this Exclusive Interview, Judith Wylie-Rosett talks with Diabetes in Control Publisher Steve Freed about the impact of artificial sweeteners on weight loss efforts as well as cardiometabolic health.

In part 5, the conclusion of this Exclusive Interview, Judith Wylie-Rosett talks with Diabetes in Control Publisher Steve Freed about her recommendations regarding talking about the use of sweeteners with patients who have diabetes. She also shares the highlights of her ADA presentation.

Diabetes in Control readers are being asked to participate in exclusive research that will provide new insights into what you think about insulin pumps and daily injections. Whether you’re a patient, a patient family member, medical professional or diabetes educator, we need to hear from you. Please take a few moments to take our survey and help our research. The survey takes only about 3 minutes, is completely anonymous, and lets you make your voice heard in analysis that can potentially influence the future of insulin delivery research and development.

The beta-cell preserving properties of short courses of metformin and insulin glargine evaluated in ever-growing population of patients who have diabetes.

Study assesses effect of new add-on therapy.

Can canagliflozin affect the progression of kidney disease in patients with type 2 diabetes?

The intestinal microbiota in people with type 1 and those with MODY2 differs in abundance and type compared to people without.

Infection risk is high among people with diabetes, but can better glycemic management improve lower infection risk?

Patients with either painful or painless neuropathy found to have low vitamin D levels.